Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
J Gastrointest Cancer ; 41(4): 261-3, 2010 Dec.
Article in English | MEDLINE | ID: mdl-20405241

ABSTRACT

INTRODUCTION: We report the first case of immunophenotypically confirmed primary hepatic Burkitt lymphoma presenting with acute liver failure. The patient survived following an aggressive diagnostic approach followed by emergent chemotherapy. DISCUSSION: Data from the primary hepatic non-Hodgkin lymphoma literature show a survival rate of 87% at 5 years with combination regimens of chemotherapy. However, mortality rate in this population is 85% in patients with acute liver failure. CONCLUSION: Primary hepatic Burkitt lymphoma may respond well to emergent chemotherapy even in the setting of acute liver failure.


Subject(s)
Burkitt Lymphoma/complications , Liver Failure, Acute/etiology , Liver Neoplasms/complications , Antibodies, Monoclonal, Murine-Derived/administration & dosage , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Antiretroviral Therapy, Highly Active , Burkitt Lymphoma/drug therapy , Burkitt Lymphoma/pathology , Cytarabine/administration & dosage , Dexamethasone/administration & dosage , Female , HIV Infections/complications , HIV Infections/drug therapy , Humans , Liver Failure, Acute/physiopathology , Liver Neoplasms/drug therapy , Liver Neoplasms/pathology , Middle Aged , Rituximab
SELECTION OF CITATIONS
SEARCH DETAIL
...